Larvol Delta - Acrivon-to-Highlight-Preclinical-Data-with-Three-Posters-at-AACR-Demonstrating-Strong-ACR368-and-ACR2316-Synergies-with-Immune-Checkpoint-Inhibitors-and-ADC-Payloads-Revealing-Broad-Clinical-Development-Opportunities

prexasertib (ACR-368) - Acrivon Therap

ACR-2316 - Acrivon Therap

https://www.globenewswire.com/news-release/2026/04/17/3276471/0/en/acrivon-to-highlight-preclinical-data-with-three-posters-at-aacr-demonstrating-strong-acr-368-and-acr-2316-synergies-with-immune-checkpoint-inhibitors-and-adc-payloads-revealing-br.html

Apr 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next